S African Druggists Set To Challenge UK, Euro Markets

7 August 1994

The SA Druggists group, one of the largest pharmaceutical manufacturers in southern Africa, is expanding the activities of its subsidiaries in the UK to spearhead an intensified export drive into British and European markets for its generic medicines.

The new company, Trinity Pharmaceuticals (formerly Meprapharm), will operate from a base in the UK's Midlands region and will trade mainly in a wide range of branded and non-branded generic drugs produced by Lennon in South Africa. It will also buy in some products from local sources, the Marketletter's local correspondent reports.

With exports accounting for almost 10% of its total turnover in 1993, the SA Druggists group is already a significant international player, which sells its products in more than 20 countries, including the UK.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight